Experts available for holiday-related stories
University of Colorado Boulder
Following a spinal cord injury, the body’s internal clocks fall out of sync, impacting temperature, hormones and immunity, according to new research funded by the U.S. Department of Defense. The findings could lead to “chronotherapies” to reset clocks and improve recovery.
A new brain imaging study shows that when we imagine something we fear, it stimulates similar neural pathways as when we experience it. The findings suggest imagination can be a powerful therapeutic tool for helping people get over phobias or post traumatic stress.
Lior Gross and Jewish Studies instructor Eyal Rivlin publicly launched their new gender-inclusive Hebrew language—the Nonbinary Hebrew Project—in late October.
CU Boulder researchers are playing an important role in a NASA mission to grab a piece of an asteroid and return it to Earth.
Carson Bruns is working to put body art to use, designing high-tech inks that may one day signal your temperature or changes in blood chemistry.
Five of the six top finishers in this month's New York City Marathon wore a cutting-edge shoe said to reduce the amount of energy required to run by 4 percent. A new study explains how the shoe works and answers some questions raised by critics.
CU Cancer Center study shows that cancer stem cells switch from metabolizing sugar to metabolizing protein. Turning off protein metabolism kills these cells.
How ideas move through academia may depend on where those ideas come from as much as their quality, a recent study suggests.
Researchers at the University of Colorado Boulder have uncovered the statistical rules that govern how gigantic colonies of fire ants form bridges, ladders and floating rafts.
University of Colorado Boulder neuroscientist Linda Watkins has developed an opioid-free, long-lasting shot for management of chronic pain. So far, it has been tested in more than 40 dogs with impressive results and no adverse effects. Human trials are underway.
Navitoclax plus A-1210477 not only killed melanoma cells, but also killed the melanoma initiating cells (aka cancer stem cells) that often resist therapy.
University of Colorado Cancer Center study shows that "normal" gene CDK1 interacts with "abnormal" gene Sox2 to keep cancer stem cells "stemmy."
A University of Colorado Cancer Center study published today in the journal Cancer Cell shows that leukemia undercuts the ability of normal cells to consume glucose, thus leaving more glucose available to feed its own growth.
CU Boulder researchers have identified a family of small molecules that turn off defense mechanisms inside bacteria that enable them to resist antibiotics. The compounds could ultimately be given alongside existing medications to rejuvenate them.